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Background: P. falciparum and HIV diseases affect the poorest group of a population that are 
made vulnerable by the lack of access to quality education, information and health facilities, all 
of which are characteristic of sub-Saharan Africa. This study was conducted to determine the 
co-infection of P. falciparum and HIV among pregnant women in Edo State, Nigeria. Methods: 
A total of 459 HIV infected pregnant women attending antenatal clinics at the Central Hospital 
Benin City, were enrolled. The age of participants ranged from 20 – 48 years. Blood specimens 
were collected from participants and analysed for HIV and P. falciparum detection, full blood 
count and CD4+ T cells count estimation. Chi squared (X2) was used for frequency data whereas 
odd ratio (OR) was analysed for each potential risk factor. Results: An overall prevalence of 
27.2% of P. falciparum infection among HIV infected pregnant women in Edo State, Nigeria 
was observed. HIV infected pregnant women that are 20-29 years age group, those single, 
primary school leavers, traders, first trimester, primiparous, use of insecticide-treated bed nets, 
rainy season and anaemia significantly affected the prevalence of P. falciparum infection 
(P<0.0.0001). Conclusion: The administration of intermittent preventive treatment (IPT) as 
early as possible during pregnancy, use of insecticide-treated bed nets and effective and prompt 
malaria management are advocated. 
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INTRODUCTION   
Malaria and HIV infections are among the most 
important public health problems worldwide (UNAIDS, 
2012). Malaria is prevalent in resource-poor settings, 
particularly occasioned by poverty, caused by 
inadequate sewage treatment, poor hygiene and 
substandard housing (Gallup and Sachs, 2001). Malaria 
remains one of the challenging infections affecting the 
lives of many HIV infected pregnant women in sub-
Saharan Africa (WHO, 2004). It is estimated that about 
24 million pregnant women are affected by P. 
falciparum yearly, majority of which are from sub-
Saharan Africa and about 1 million are co-infection with 
HIV (Steketee et al., 2001; WHO, 2004). HIV infection 
constitutes the leading cause of death among women of 
reproductive age and as such is considered an important 
 
maternal problem worldwide (Tang and Nour, 2010). 
HIV infected pregnant women are at increased risk of 
maternal anaemia, adverse pregnancy outcomes 
including low birth weights, stillbirths, infant morbidity 
and high mortality (Braddick et al., 1990; Robbins et al., 
2007; Naniche et al., 2009; Zaba et al., 2013). 
It has been reported that HIV infected pregnant women 
have an increased susceptibility to malaria (van Eijk et 
al., 2003). The co-infection of malaria and HIV infection 
have been reported to cause more than 4 million deaths 
annually (WHO, 2003). HIV and malaria epidemics 
overlap in sub-Saharan Africa (Meshnick et al., 2006). 
P. falciparum and HIV diseases affect the poorest group 
of a population that are made vulnerable by the lack of 
access to quality education, information and health 
facilities, all of which are characteristics of sub-Saharan 
Africa (Kwenti, 2018). These two diseases interactions 
are particularly significant in pregnant women as they 
form one of the most vulnerable population groups in 
sub-Saharan Africa (Uneke and Ogbonna, 2009). The 
interactions between the two diseases are bidirectional 
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with each disease exacerbating the other (Gonzalez et 
al., 2012; Gonzalez and Naniche, 2015).  
In Nigeria, both diseases are still serious life-threatening 
problems among pregnant women. P. falciparum and 
HIV are among the leading causes of morbidity in 
pregnancy where modest effects of one infection on the 
other could lead to a substantial negative impact on the 
health of pregnant women and the neonates (Corbett et 
al., 2002). Without a timely intervention, it is estimated 
that approximately 25 – 45 % of the HIV infected 
women will transmit infection to their children (Dabis 
and Ekpini, 2002). Information is lacking on the co-
infection of P. falciparum and HIV among pregnant 
women in Edo State, Nigeria. As such pregnant women 
and their foetuses are exposed to the risk of malaria and 
HIV infections as both diseases overlap in Edo State. 
Against this background, this study was conducted to 
determine the co-infection of P. falciparum and HIV 




The study was conducted at the Central Hospital, Benin 
City, Edo State, a secondary referral health institution 
and a centre for HIV/AIDS management. 
 
Study population 
This study was conducted between November 2018 and 
June 2019 at the Central Hospital, Benin City, Edo State. 
A total of 459 HIV infected pregnant women attending 
antenatal clinics at the Central Hospital, Benin City were 
enrolled in this study. HIV infected pregnant women on 
HAART attending antenatal care clinics, those that 
were 20 years and above and those that consented to 
participate in the study were enrolled. Pregnant 
women that were less than 20 years and those with 
life-threatening medical and obstetrical conditions 
and those not on HAART were excluded from this 
study. The agents used in the HAART regimen for 
HIV infected patients consist of zidovudine, 
lamividine and nevirapine. A well- structured 
questionnaire bothering on biodata and 
sociodemographic characteristics was administered to 
each participant. Informed consent was obtained from 
study participants prior to specimen collection. The 
protocol for this study was approved by the Ethics and 
Research Committee of the Ministry of Health, Benin 
City, Edo State. 
 
Collection of specimens 
About 5 ml of venous blood was obtained from each 
participant and dispensed into ethylene diamine tetra 
acetic acid containers. 
About 5 ml of venous blood was obtained from each 
participant and dispensed into ethylene diamine tetra 
acetic acid containers. 
 
Processing of specimens 
Pregnant women were screened for HIV using the 
Determine HIV 1/2 rapid immunoassay test strip. 
Positive cases were confirmed using the trinity Unigold 
HIV 1/2 kit (CDC, 2014). 
Thick and thin blood films were made from each blood 
specimen, allowed to air-dry and stained in 1:10 dilution 
of Giemsa stain for 30 min. The stained blood films were 
rinsed in buffer solution and allowed to air dry. The 
stained thick films were examined for malaria parasites 
detection whereas the thin blood film was used for 
speciation by light microscopy. A total of 200 high 
power fields per blood film were examined 
(Cheesbrough, 2000).  
The blood samples were analysed for full blood count 
using an auto-analyser Sysmex Kx-21 (Sysmex 
Corporation, Kobe, Japan). Anaemia was determined 
using haemoglobin concentration <11g/dl for pregnant 
women (Beutler and Waalen, 2006). 
CD4+ T cells counts were determined using the flow 
cytometry (Partec, Gmbh, Germany). Briefly, 20L of 
monoclonal antibodies were added and incubated in the 
dark for 15 min at room temperature after which 800L 
of buffer was added. The tube containing the mixture 
was plugged to the flow cytometer for counting and the 
value of CD4+T cells obtained from a programmed 
monitor connected to the flow cytometer. 
 
Data analysis 
The data obtained were analysed using Chi squared (X2) 
test in comparing the frequency data while the odd ratios 
(OR) were calculated for potential risk factors at 0.05 
significance level. The statistical package used in the 
data analyses was INSTAT (GraphPad software Inc, La 
Jolla, CA, USA). 
 
RESULTS 
Out of the 459 HIV infected pregnant women attending 
antenatal clinics at the Central Hospital, Benin City, 125 
(27.2%) had P. falciparum infection. Age significantly 
affected the prevalence of P. falciparum infection 
among HIV infected pregnant women (P=0.0183) with 
the 20-29 years age group having the highest prevalence 
(31.1%). Marital status strongly affected P. falciparum 
infection among HIV infected pregnant women 
(P=0.0050) where single HIV infected pregnant women 
had the highest prevalence (44.3%). HIV infected 
pregnant women who are primary school leavers 
presented with the highest prevalence of P. falciparum 
(49.3%) followed by those with tertiary education 
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(20.7%) and the least was those with secondary 
education (17.6%). In addition, educational status 
significantly affected the prevalence of P. falciparum 
infection among HIV infected pregnant women. Traders 
were significantly more prone to P. falciparum infection 
among HIV pregnant women (P<0.0001). HIV infected 
pregnant women in their first trimester were more likely 
to be infected with P. falciparum (P<0.0001). 
Primiparous HIV infected pregnant women were more 
prone to malaria infection (P<0.0001) with a 1 to 4-fold 
risk of acquisition. Participants that used insecticide 
treated bed nets had significantly lower prevalence of P. 
falciparum infection (P=0.0021). Seasonal variation 
significantly affected the prevalence of P. falciparum 
infection among HIV infected pregnant women 
(P<0.0001) with the rainy season recording higher 
prevalence (45.5%) than the dry season (14.4%) (Table 
1). 
 
Table 1: Relationship between demographic characteristics 
and co-infection of P. falciparum and HIV among pregnant 
women 
 
OR=Odd ratio; CI=Confidence interval; * P<0.05 
 
 
There was a strong association between anaemia and P. 
falciparum infection among HIV infected pregnant 
women (OR=4.738; 95% CI= 2.851, 7.875; P<0.0001). 
CD4+ T cells less than 200cells/L did not strongly 
associate with the prevalence of P. falciparum infection 
among HIV infected pregnant women (P=0.9081) 
(Table 2). 
DISCUSSION 
Human immunodeficiency virus and malaria infections 
represent the most important health problems in sub-
Saharan Africa, where these infections overlap and co-
infection is rampant (Abu-Raddad et al., 2006). Co-
infection with malaria and HIV presents specific 
complications for pregnant women and foetal 
development. The interactions between these two 
diseases during pregnancy are complex (Guyatt and 
Snow, 2004) thus, putting the life of the pregnant women 
and their unborn babies at risk of medical and poor 
obstetrical conditions and threatening antiretroviral and 
antimalarial treatments effectiveness. To our 
knowledge, this is the first study on the co-infection of 
P. falciparum and HIV among pregnant women in Edo 
State, Nigeria. 
An overall prevalence of 27.2% of P. falciparum 
infection was observed among HIV infected pregnant 
women in Edo State. The prevalence of 27.2% reported 
in our study is lower than the 33.4% observed by 
Houmsou et al. (2014) in Benue State, Central Nigeria, 
the 47.7% reported by Sanyaolu et al. (2013) in Lagos, 
South West Nigeria and 49.83% recorded by Johnbull et 
al. (2014) in Enugu, South East Nigeria. In areas with 
stable malaria transmission such as our study area, HIV 
has been reported to increase the risk of malaria infection 
and clinical malaria in adults, especially those with 
advanced immunosuppression (Berg et al., 2014).  The 
difference in our work and that of other studies may be 
attributed to geographical locations and the efforts of the 
MTCT unit at caring for HIV-infected pregnant women 
and ensuring compliance in taking their medications.  
 
Table 2: Effect of anaemia and CD4+ T cell counts on the co-




Age has been reported as a co-factor in disease 
progression, and the immunity to malaria and HIV 
infection has been observed to be age-dependent 
(Schwartz et al., 2001). In this study, age significantly 
affected the prevalence of P. falciparum infection 
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among HIV infected pregnant women (P=0.0183) with 
the 20-29 years age group having the highest prevalence 
(31.1%). This finding is in contrast to that observed by 
Houmsou et al. (2014) that did not find an association 
between malarial infection in HIV infected pregnant 
women in Benue State, Nigeria.  
Being single strongly associated with P. falciparum 
infection among HIV infected pregnant women 
(P=0.0050). This finding is at variance with the report of 
Houmsou et al. (2014) that observed increased malaria 
infection among divorcees. The reason for the difference 
may be due to the fact that singles are more likely to 
engage in several occupations that may expose them to 
mosquito bites.  
In this study, educational status significantly impacted 
on the prevalence of P. falciparum infection (P<0.0001)  
where those with primary school education presented 
with the highest prevalence (47.3%).  
Traders were observed to be more likely to acquire P. 
falciparum infection among HIV infected pregnant 
women (P<0.0001). This is because they are exposed to 
the bite of mosquitoes as they carry out their activities 
mostly around breeding mosquito sites. This may 
explain the reason for this finding. 
HIV infected pregnant women who are in their first 
trimesters were found to be at risk in acquiring P. 
falciparum (P<0.0001) when compared with other 
trimesters which imply that most of the women enrolled 
in our study are at risk of adverse pregnancy outcomes. 
This finding is in tandem with the previous study of 
Houmsou et al. (2014) that observed that HIV infected 
pregnant women in their first trimester are more likely 
to be infected with P. falciparum. It has been observed 
that pregnant women in their first trimester are unlikely 
yet to be administered sulphadoxine-pyrimethamine 
used as the intermittent preventive treatment (IPT) that 
are usually given only to women at their second and third 
trimesters (Houmsou et al., 2014).  
First pregnancy is believed to be the most critical as 
women develop pregnancy-specific immunity against 
placental parasites over successive pregnancies resulting 
from repeated exposure (Flateau et al., 2011). Albeit, 
available information suggest that women who are 
infected with HIV have the same low level of immunity 
to malaria in subsequent pregnancies as they do in their 
first pregnancy and are twice as susceptible to clinical 
malaria, which increases the risk of adverse outcomes 
(Brenthinger et al., 2006; Flateau et al., 2011). In our 
study, primiparous HIV infected pregnant women are at 
1 to 4 -fold increased risk of acquiring P. falciparum 
infection when compared with their multiparous 
counterparts (OR=2.871; 95% CI= 1.876, 4.396; 
P<0.0001). 
Generally, the use of insecticide treated bed net is a 
recognized effective way of preventing malaria infection 
(Akinbo et al., 2014). HIV infected pregnant women that 
used insecticide treated bed nets had significantly the 
least prevalence of P. falciparum infection (18.5%; 
P=0.0021) compared with other preventive measures. 
The World Health Organization recommends a three-
pronged approach for malaria control during pregnancy 
in sub-Saharan Africa: intermittent preventive treatment 
(IPT), insecticide treated bed nets and effective case 
management of malaria illness (WHO, 2012). Thus, HIV 
infected pregnant women be issued and encouraged to 
use insecticide treated bed nets in order to reduce the 
adverse pregnancy outcomes occasioned by P. 
falciparum infection. 
Parasite transmission and development are regarded to 
be influenced by climatic conditions particularly within 
the temperature range of 25-30oC (Egbendewe-
Mondzozo et al., 2011). There is a direct influence of 
temperature and rainfall on the number and productivity 
of breeding sites, ultimately the vector density (Afrane 
et al., 2012). This study observed P. falciparum 
infection peaked during rainy season among HIV 
infected pregnant women (P<0.0001). Rainy season has 
been reported to provide ecological changes favouring 
the breeding of the mosquito vectors which enhance the 
transmission of malaria (Erhabor et al., 2014). 
HIV infected pregnant women with malaria had a 2 to 7-
fold higher risk of developing anaemia (OR= 4.738; 
95% CI= 2.851, 7.875; P<0.0001). This observation 
agrees with previous reports of Johnbull et al. (2014) and 
Houmsou et al. (2014). The cause of anaemia in 
pregnancy is multifactorial and may include 
haemodilution infections particularly HIV and malaria, 
inadequate erythropoiesis (Agan et al., 2010). Both HIV 
and malaria are known causes of maternal anaemia 
(Moses et al., 1998; Guyatt and Snow, 2001). In 
addition, the presence of zidovudine among the HAART 
regimen used by our subjects and antibodies to HAART 
agents have been reported to be associated with anaemia 
(Moyle, 2002). The risk of anaemia secondary to malaria 
and HIV infection could be reduced through prompt, 
effective treatment and follow up during pregnancy in 
order to increase the chances of delivering a healthy 
infant. Adequate information about nutritional diet could 
also play a big role in reducing adverse pregnancy 
outcomes necessitated by anaemia. 
It has been reported that independently, HIV and malaria 
interact with the host immune system to bring about 
complex activation of immune cells, which causes 
dysfunctional levels of cytokine and antibody 
production (Hochman and Kim, 2009). Furthermore, 
CD4+ T cells play a major part in the development and 
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maintenance of antimalaria immunity, but HIV 
interferes with immunity (Troye-Blomberg and Berzins, 
2008) by widespread lymphoid necrosis throughout the 
lymph nodes, spleen, and gut mucosae, hyperactivation 
of CD4+ and CD 8+ effector cells to secrete cytokines, 
HIV induced downregulation of CD4+ T cells, decreases 
in CD8+ T-cells counts, and upregulation of parasitemia, 
consequently leading to fatal malaria and a rapid 
progression to AIDS (Ryan-Payseur et al., 2011). 
Surprisingly, CD4+ T-cells count did not strongly 
associate with co-infection of malaria and HIV among 
pregnant women in this study (OR= 0.9641; 95% CI = 
0.6106, 1.522; P=0.9081). The low malarial infection 
observed in those with CD4+ T cell counts greater than 
200 cells/L could be the reconstitution of their immune 
system due to highly active antiretroviral therapy 
(HAART) or recently infected pregnant women that still 
have strong immune system. This may explain the 
reason for our finding. 
 
CONCLUSION 
This study reveals a prevalence of 27.2% of P. 
falciparum infection among HIV infected pregnant 
women in Edo State, Nigeria. HIV infected pregnant 
women that are 20-29 years age group, those single, 
primary school leavers, traders, first trimester, 
primiparous, those that use insecticide treated bed nets 
and rainy season significantly affected the prevalence of 
P. falciparum infection in this study (P<0.0001). In 
addition, anaemia strongly associated with P. falciparum 
infection among HIV infected pregnant women 
(P<0.0001). The administration of intermittent 
preventive treatment as early as possible during 
pregnancy, use of insecticide-treated bed nets and 
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